CIM LLC’s Pfizer PFE Stock Holding History

CIM LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,281	Closed	-$1.55M	–	159
2022 Q3	$1.55M	Buy	32,281 +2,196	+7%	+$107K	0.33%	56
2022 Q2	$1.6M	Buy	30,085 +2,129	+8%	+$108K	0.33%	51
2022 Q1	$1.51M	Buy	+27,956	New	+$1.45M	0.28%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIM LLC's PFE Position: Q4 2022 in Review

CIM LLC sold out of Pfizer (PFE) in Q4 2022, closing a stake of 32,281 shares — an estimated $1.55M sold.

CIM LLC first reported a position in PFE in Q1 2022 and held it in 3 quarters. The position peaked at $1.6M in Q2 2022. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

CIM LLC reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
CIM LLC sold 32,281 Pfizer shares in Q4 2022, an estimated $1.55M.
CIM LLC first reported a position in Pfizer in Q1 2022 and held it in 3 quarters.
CIM LLC's Pfizer position peaked at $1.6M in Q2 2022.
3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on CIM LLC's 13F filing for Q4 2022, filed 10 Feb 2023.